ESC 365 - Transthyretin cardiac amyloidosis: pathophysiology and consequences

ESC2025 Premium Access

Transthyretin cardiac amyloidosis: pathophysiology and consequences

Session: Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?

Topic: Pharmacotherapy

Speaker: Doctor A. Masri (Portland, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)

18 presentations

1 follower

4 more presentations in this session

Cardiac imaging of amyloid

Speaker: Professor P. Lindqvist (Umea, SE)

Stabilisers, silencers, and depleters: how do they work?

Speaker: Professor M. Fontana (London, GB)

Stabilisers, silencers, and depleters: how should I use them?

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure? - discussion

Access the full session

Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?

Speakers: Doctor A. Masri, Professor P. Lindqvist, Professor M. Fontana, Doctor P. Garcia-Pavia

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources